United Therapeutics shareholders approve 2026 stock incentive plan at annual meeting

United Therapeutics Corporation

UTHR

0.00

United Therapeutics held its annual shareholder meeting on June 26, 2026.
Shareholders adopted the 2026 Stock Incentive Plan, effective June 26, 2026.
The plan authorizes equity awards such as stock options, restricted stock, restricted stock units, stock appreciation rights, stock awards, performance-based awards, and incentive bonuses.
No further awards will be made under the prior 2015 stock incentive plan; remaining share capacity will roll into the new plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-078865), on June 29, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.